Srivatsan Raghavan

Medical oncologist and physician-scientist at Dana-Farber Cancer Institute and Harvard Medical School, where he leads research into pancreatic and biliary cancers. His lab uses experimental and computational methods to investigate cancer cell states, treatment resistance, and potential therapeutic targets.